GBCS (Selectis Health) ROE %: Negative Equity% (As of Mar. 2026)


GBCS Selectis Health Inc GBCS
45 GF Score
Price $5.22
GF Value $2.14
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Selectis Health ROE %?

Selectis Health GBCS -3.33% 45 ROE % is Negative Equity% as of Mar. 2026. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Selectis Health ranks better than 99.84% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Selectis Health's annualized net income for the quarter that ended in Mar. 2026 was $26.10 Mil. Selectis Health's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $-2.98 Mil. Therefore, Selectis Health's annualized ROE % for the quarter that ended in Mar. 2026 was Negative Equity%.

The historical rank and industry rank for Selectis Health's ROE % or its related term are showing as below:

GBCS' s ROE % Range Over the Past 10 Years
Min: -118.18   Med: -83.51   Max: 148.36
Current: Negative Equity

During the past 13 years, Selectis Health's highest ROE % was 148.36%. The lowest was -118.18%. And the median was -83.51%.

GBCS's ROE % is ranked better than
99.84% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs GBCS: Negative Equity

Selectis Health  (OTCPK:GBCS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=26.104/-2.9765
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(26.104 / 29.156)*(29.156 / 31.295)*(31.295 / -2.9765)
=Net Margin %*Asset Turnover*Equity Multiplier
=89.53 %*0.9317*N/A
=ROA %*Equity Multiplier
=83.42 %*N/A
=Negative Equity %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=26.104/-2.9765
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (26.104 / 27.744) * (27.744 / -5.048) * (-5.048 / 29.156) * (29.156 / 31.295) * (31.295 / -2.9765)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9409 * -5.496 * -17.31 % * 0.9317 * N/A
=Negative Equity %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Selectis Health ROE % Related Terms


Selectis Health ROE % Historical Data

* Premium members only.

The historical data trend for Selectis Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selectis Health ROE % Chart

Selectis Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -69.12 -118.18 0.00 0.00 0.00

Selectis Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 Negative Equity 0.00 Negative Equity

GBCS vs AMS, BICX, NUMIF: ROE % Comparison

For the Medical Care Facilities subindustry, Selectis Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selectis Health ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's ROE % distribution charts can be found below:

* The bar in red indicates where Selectis Health's ROE % falls into.


GBCS
45GF Score
Selectis Health Inc GBCS
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selectis Health ROE % Calculation

Selectis Health's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-1.016/( (-5.41+-6.211)/ 2 )
=-1.016/-5.8105
=N/A %

Selectis Health's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=26.104/( (-6.211+0.258)/ 2 )
=26.104/-2.9765
=Negative Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of Negative Equity% mean?
Selectis Health (GBCS) has a ROE % of Negative Equity% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Selectis Health and its competitors. According to the industry distribution chart, Selectis Health ranks #1 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Selectis Health's ROE % too high?
Selectis Health's current ROE % is Negative Equity%. Based on the distribution chart, Selectis Health ranks #1 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's ROE % compare to AMS and BICX?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #1 out of 628 companies for ROE %. This places Selectis Health in the top 0% of its industry — outperforming the majority of peers. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current ROE % is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.22 — trading 143.9% above its estimated fair value. The current ROE % is Negative Equity%. Selectis Health's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Selectis Health (GBCS), the current ROE % is Negative Equity% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.22 is trading 143.9% above its estimated GF Value™ of $2.14. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • ROE %: Negative Equity%
  • GF Value™: $2.14 vs. price of $5.22 (143.9% above fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score

Get the complete analysis for GBCS

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.22
Price
$2.14
GF Value